Pharmacy and Therapeutics Committee's Newsletter
P&T Newsletters

December 2016

·         Let’s Be Rational: Measuring the Appropriate Use of Medications

·         The Joint Commission: Formulary Management and P&T Activities

·         Transparency and Quality of International Drug Manufacturing

·         Formulary Update: November 2016


November 2016

·         Updated Pneumonia Guidelines

·         FDA and Fluoroquinolones

·         Formulary Update: October 2016


October 2016

§  Novel Treatments for Melanoma

§  USP <800> and Hazardous Drugs

§  Formulary Update: September 2016


September 2016

§  Formulary System and Restrictions

§  Automatic Therapeutic Substitutions

§  Formulary Update: August 2016


August 2016

§  Update to the Practice Guidelines for the Management of Candidiasis

§  Antimicrobial Stewardship: A Health Care Team Effort

§  Formulary Update: July 2016


July 2016

§  Keeping up with FDA’s Fast Approval Pathways

§  Did You Know?

o   Antibiotic Overprescribing

§  Formulary Update: June 2016


June 2016

§  Reversal Agents

§  STD Treatment Guideline Updates

§  Formulary Update: May 2016


April/May 2016

§  The Zika Virus

§  US Dietary Guidelines: 2015-2020

§  Formulary Update: March/April 2016


March 2016

§  Optimizing the Heparin Protocols: A Step in the Right Direction

§  New Uses for Old Drugs: Ketamine and Lidocaine for Refractory Pain

§  Formulary Update: February 2016


January/February 2016

§  A Look Into the Rising Costs of Medications in the Inpatient Setting

§  New Drug Approvals 2015

§  Formulary Update: January 2016


December 2015

§  Superbugs

§  Micro-needle Patch for Vaccine Administration

§  Formulary Update: November 2015


November 2015

§  HIV Guidelines on HAART Initiation and Pre-exposure Prophylaxis

§  How Zarxio® Made It to Market: Is There a Future for Other Biosimilars?

§  Did You Know?

o   Clinical Forms Optimization

§  Formulary Update: October 2015


October 2015

§  FDA Update: Codeine in Children

§  Did You Know?

o   Influenza Vaccinations

o   New FDA Resources

§  Formulary Update: September 2015


September 2015

§  Sulfonamide Allergic Cross-Reactivity

§  Drug-Disease Medication Alerts

§  Formulary Update: August 2015


August 2015

§  Medical Marijuana: How Strong is the Case for Pediatric Epilepsy?

§  Tickborne Diseases

§  Formulary Update: July 2015


July 2015

§  Generic Medications

§  Did You Know?

o   Medication Reconciliation

§  Medication Use Evaluation Report

o   Clostridium difficile Infections in Hematology/Oncology Patients

§  Formulary Update: June 2015


May/June 2015

§  New Hepatitis C Medication

o   New Direct-acting Antiviral Agents (DAAs) and Update Hepatitis C Guidelines

o   Medication Use Evaluation of DAAs

§  Formulary Update: April/May 2015


April 2015

§  Guidelines Updates for the Primary Prevention of Stroke

§  Did you Know?

o   Decision Support Oversight Committee

§  The Sixth Right of Medication Administration

§  Formulary Update: March 2015


March 2015

§  Update on Measles Outbreaks and Vaccination

§  Vaccine Discovery, Development, and Approval

§  Did you Know?

o   New Drug Interactions

o   FDA Drug Shortage Mobile App

§  Formulary Update: February 2015


For archived editions of Pharmacy & Therapeutics: Drug Information for Healthcare Professionals, please contact the MUSC Drug Information Center at

This site is intended for the staff of Medical University of South Carolina.
While others may view accessible pages, Medical University of South Carolina makes no warranty, express or implied,
as to the use of this information outside of Medical University of South Carolina.